J. Louie

Galunisertib plus neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer: a single-arm, phase 2 trial.

W. Urba, R. Ahmad, M. Whiteford, 2022, The Lancet. Oncology.

Intensity-modulated radiotherapy for head-and-neck cancer in the community setting.

C. Cha, S. Seung, D. Gannett, 2008, International journal of radiation oncology, biology, physics.

Selective dose escalation of chemoradiotherapy for esophageal cancer: role of treatment intensification.

J. Regan, J. W. Smith, John W. Smith, 2004, Seminars in oncology.

Neoadjuvant chemoradiotherapy for esophageal cancer using weekly Paclitaxel and Carboplatin plus infusional 5-Fluorouracil.

D. Gannett, Jeannie Louie, R. Wolf, 2007, Gastrointestinal cancer research : GCR.

Intensity-modulated radiotherapy for head-and-neck cancer in the community setting.

C. Cha, S. Seung, D. Gannett, 2008, International Journal of Radiation Oncology, Biology, Physics.

A Phase II Trial of TGFβ Type I Receptor Inhibitor, Galunisertib, plus Neoadjuvant Chemoradiation in Patients with Locally Advanced Rectal Cancer

W. Urba, G. Vaccaro, M. Crittenden, 2022, International Journal of Radiation Oncology*Biology*Physics.